FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:548 August 12, 1999 Number 7

Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hamm, C. W.

Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels . On page 1626, the curves in Figure 2B were mislabeled. The corrected figure appears below.

View larger version (4K): [in this window] [in a new window]   Corrected Figure.

 
Corrected Figure.

This article has been cited by other articles:

• Newby, L. K., Ohman, E. M., Christenson, R. H., Moliterno, D. J., Harrington, R. A., White, H. D., Armstrong, P. W., Van de Werf, F., Pfisterer, M., Hasselblad, V., Califf, R. M., Topol, E. J. (2001). Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T-Positive Status : The PARAGON-B Troponin T Substudy. Circulation 103: 2891-2896 [Abstract] [Full Text]  
• Ohman, E. M., Granger, C. B., Harrington, R. A., Lee, K. L. (2000). Risk Stratification and Therapeutic Decision Making in Acute Coronary Syndromes. JAMA 284: 876-878 [Full Text]